CIBC World Market
SAGE icon

CIBC World Market’s Sage Therapeutics SAGE Stock Holding History

CIBC World Market’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4,130
Closed -$646K – 1220
2018
Q2 		$646K Buy
4,130
+580
+16% +$91.1K ﹤0.01% 795
2018
Q1 		$572K Sell
3,550
-880
-20% -$149K ﹤0.01% 807
2017
Q4 		$730K Buy
+4,430
New +$429K ﹤0.01% 480

Other funds holding SAGE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
OppenheimerFunds
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BB Biotech
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

CIBC World Market's SAGE Position: Q3 2018 in Review

CIBC World Market sold out of Sage Therapeutics (SAGE) in Q3 2018, closing a stake of 4,130 shares — an estimated $646K sold.

CIBC World Market first reported a position in SAGE in Q4 2017 and held it in 3 quarters. The position peaked at $730K in Q4 2017. 275 funds tracked by Wall St. Rank hold SAGE as of Q3 2018.

  • CIBC World Market reported no remaining Sage Therapeutics position as of Q3 2018 after selling out during the quarter.
  • CIBC World Market sold 4,130 Sage Therapeutics shares in Q3 2018, an estimated $646K.
  • CIBC World Market first reported a position in Sage Therapeutics in Q4 2017 and held it in 3 quarters.
  • CIBC World Market's Sage Therapeutics position peaked at $730K in Q4 2017.
  • 275 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2018.

Based on CIBC World Market's 13F filing for Q3 2018, filed 9 Nov 2018.